| Pancreatic and Hepatic Oncology Research | Lifetime | 3 | DE 1 | 99.97 |
| Pancreatitis Pathology and Treatment | Lifetime | 2 | DE 1 | 99.94 |
| Neuroendocrine Tumor Research Advances | Lifetime | 3 | DE 1 | 99.91 |
| Gallbladder and Bile Duct Disorders | Lifetime | 35 | DE 2 | 99.72 |
| Renal cell carcinoma treatment | Lifetime | 82 | DE 1 | 99.45 |
| Colorectal Cancer Surgical Treatments | Lifetime | 89 | DE 2 | 99.35 |
| Cholangiocarcinoma and Gallbladder Cancer Studies | Lifetime | 163 | DE 5 | 99.13 |
| Gastric Cancer Management and Outcomes | Lifetime | 366 | DE 17 | 99.15 |
| Cancer Genomics and Diagnostics | Lifetime | 400 | DE 21 | 99.24 |
| Esophageal and GI Pathology | Lifetime | 484 | DE 22 | 98.32 |
| Gastrointestinal Tumor Research and Treatment | Lifetime | 314 | DE 13 | 98.14 |
| Colorectal and Anal Carcinomas | Lifetime | 281 | DE 18 | 98.07 |
| Hepatocellular Carcinoma Treatment and Prognosis | Lifetime | 547 | DE 15 | 98.32 |
| Corrosion Behavior and Inhibition | Lifetime | 462 | DE 19 | 97.62 |
| Cancer Research and Treatments | Lifetime | 836 | DE 39 | 96.24 |
| Cancer Cells and Metastasis | Lifetime | 982 | DE 81 | 96.36 |
| Pediatric Hepatobiliary Diseases and Treatments | Lifetime | 624 | DE 34 | 96.83 |
| TGF-β signaling in diseases | Lifetime | 305 | DE 17 | 95.63 |
| Abdominal vascular conditions and treatments | Lifetime | 276 | DE 12 | 94.93 |
| Appendicitis Diagnosis and Management | Lifetime | 544 | DE 24 | 95.67 |
| Hydrogen embrittlement and corrosion behaviors in metals | Lifetime | 676 | DE 29 | 96.48 |
| Enhanced Recovery After Surgery | Lifetime | 324 | DE 12 | 94.29 |
| Abdominal Surgery and Complications | Lifetime | 482 | DE 29 | 92.48 |
| Anorectal Disease Treatments and Outcomes | Lifetime | 894 | DE 35 | 93.14 |
| Fibroblast Growth Factor Research | Lifetime | 792 | DE 37 | 91.28 |
| Cancer, Stress, Anesthesia, and Immune Response | Lifetime | 695 | DE 43 | 89.99 |
| Stoma care and complications | Lifetime | 359 | DE 9 | 87.62 |
| Medical Practices and Rehabilitation | Lifetime | 629 | DE 495 | 82.73 |
| Connective Tissue Growth Factor Research | Lifetime | 482 | DE 42 | 81.96 |
| Academic Publishing and Open Access | Lifetime | 937 | DE 43 | 43.11 |
| Pancreatic and Hepatic Oncology Research | 2021-2025 | 29 | DE 3 | 99.50 |
| Pancreatitis Pathology and Treatment | 2021-2025 | 54 | DE 3 | 98.31 |
| Renal cell carcinoma treatment | 2021-2025 | 161 | DE 6 | 97.25 |
| Neuroendocrine Tumor Research Advances | 2021-2025 | 283 | DE 16 | 94.13 |
| Gallbladder and Bile Duct Disorders | 2021-2025 | 358 | DE 16 | 94.20 |
| Cholangiocarcinoma and Gallbladder Cancer Studies | 2021-2025 | 592 | DE 30 | 91.48 |
| Gastrointestinal Tumor Research and Treatment | 2021-2025 | 798 | DE 29 | 83.70 |
| Cancer, Stress, Anesthesia, and Immune Response | 2021-2025 | 895 | DE 20 | 57.78 |
